Clinical News Roundup: Artificial Intelligence Ready To Run Clinical Trials

By Ed Miseta, Chief Editor, Clinical LeaderFollow Me On Twitter @EdClinical There are those who believe that artificial intelligence (AI) can make clinical trials cheaper and faster. We are about to find out if that hypothesis is true. A British start-up is about to begin testing its AI technology to optimize drug development. BenevolentAI specializes in AI, and its BenevolentBio division, formerly Stratified Medical, is now applying it to human health and biotech. The technology is expected to speed up late-stage development of drugs and provide richer clinical data. The company has announced it will test the technology using clinical stage drug candidates licensed from Janssen. Although there are no details on the agreement, BenevolentAI is confident that it can accelerate clinical development and begin Phase 2b trials in mid-2017.…


Link to Full Article: Clinical News Roundup: Artificial Intelligence Ready To Run Clinical Trials

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about homeAI.info and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!